Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

New horizons in cellular immunotherapy: next-gen platforms and modalities

Guest Editor: Dr David Morrow, ATMP & Vaccine Scientific Programme Manager, Translational Medicine & Drug Development, EATRIS
  • New horizons in immuno-oncology:
    • How are emerging autologous and allogeneic approaches and immune cell types performing in preclinical and early clinical studies?
      • What is the evidence to date that they can improve rates and durability of response and address lingering safety concerns?
      • Next steps in targeting and tackling solid tumours: what have we learned from earlier approaches?
    • Preclinical to clinical translatability: overcoming in vivo hurdles for immuno-oncology therapies
    • Window on future enabling technologies: what impact will tools such as genome and epigenome editing have on the immunooncology space moving forward?
    • How are novel therapeutics combinations performing in clinical applications?
  • The dawn of cellular immunotherapy in non-cancer: evaluating the promise of novel approaches in tolerisation, autoimmune diseases and diabetes.
COMING IN OCTOBER 2020
Twitter IconVisit Our Blog